Tim Chiang

Stock Analyst

(n/a)
# 4,648
Out of 4,655 analysts
21
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Tim Chiang

Heron Therapeutics
Apr 23, 2024
Initiates: Overweight
Price Target: $6
Current: $1.78
Upside: +237.08%
Protagonist Therapeutics
Oct 30, 2023
Initiates: Overweight
Price Target: n/a
Current: $46.76
Upside: -
Jasper Therapeutics
Aug 11, 2023
Initiates: Overweight
Price Target: $70
Current: $21.27
Upside: +229.10%
Amphastar Pharmaceuticals
Jul 29, 2022
Initiates: Overweight
Price Target: $44
Current: $50.73
Upside: -13.27%
KALA BIO
Mar 30, 2022
Maintains: Outperform
Price Target: $300$200
Current: $6.99
Upside: +2,761.23%
Pacira BioSciences
May 5, 2021
Maintains: Market Perform
Price Target: $75$66
Current: $16.57
Upside: +298.31%
Repare Therapeutics
Oct 28, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.58
Upside: -
Verrica Pharmaceuticals
Jun 24, 2020
Initiates: Outperform
Price Target: $21
Current: $1.53
Upside: +1,272.55%
Teva Pharmaceutical
Sep 17, 2018
Upgrades: Neutral
Price Target: n/a
Current: $18.45
Upside: -
Summit Therapeutics
Feb 13, 2018
Initiates: Buy
Price Target: $33
Current: $18.99
Upside: +73.78%